Trade Valneva SE - VLA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020029% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002193% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.11 |
| Open | 2.11 |
| 1-Year Change | -63.75% |
| Day's Range | 1.99 - 2.14 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | 2.00 | -0.11 | -5.21% | 2.11 | 2.14 | 1.98 |
| Nov 20, 2024 | 2.11 | 0.02 | 0.96% | 2.09 | 2.15 | 2.07 |
| Nov 19, 2024 | 2.11 | 0.05 | 2.43% | 2.06 | 2.12 | 2.06 |
| Nov 18, 2024 | 2.09 | -0.01 | -0.48% | 2.10 | 2.16 | 2.07 |
| Nov 15, 2024 | 2.17 | -0.02 | -0.91% | 2.19 | 2.24 | 2.09 |
| Nov 14, 2024 | 2.33 | -0.03 | -1.27% | 2.36 | 2.41 | 2.30 |
| Nov 13, 2024 | 2.36 | 0.07 | 3.06% | 2.29 | 2.38 | 2.21 |
| Nov 12, 2024 | 2.24 | -0.05 | -2.18% | 2.29 | 2.35 | 2.24 |
| Nov 11, 2024 | 2.40 | 0.02 | 0.84% | 2.38 | 2.46 | 2.38 |
| Nov 8, 2024 | 2.40 | -0.06 | -2.44% | 2.46 | 2.50 | 2.39 |
| Nov 7, 2024 | 2.51 | -0.06 | -2.33% | 2.57 | 2.69 | 2.48 |
| Nov 6, 2024 | 2.57 | -0.02 | -0.77% | 2.59 | 2.66 | 2.55 |
| Nov 5, 2024 | 2.61 | 0.00 | 0.00% | 2.61 | 2.67 | 2.51 |
| Nov 4, 2024 | 2.63 | 0.01 | 0.38% | 2.62 | 2.68 | 2.60 |
| Nov 1, 2024 | 2.64 | 0.11 | 4.35% | 2.53 | 2.65 | 2.53 |
| Oct 31, 2024 | 2.57 | -0.02 | -0.77% | 2.59 | 2.65 | 2.56 |
| Oct 30, 2024 | 2.66 | -0.04 | -1.48% | 2.70 | 2.77 | 2.65 |
| Oct 29, 2024 | 2.74 | -0.02 | -0.72% | 2.76 | 2.76 | 2.71 |
| Oct 28, 2024 | 2.78 | 0.09 | 3.35% | 2.69 | 2.79 | 2.67 |
| Oct 25, 2024 | 2.68 | 0.01 | 0.37% | 2.67 | 2.70 | 2.66 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Valneva SE Company profile
About Valneva SE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Financial summary
BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.
Equity composition
07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).
| Industry: | Biotechnology & Medical Research (NEC) |
6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com